These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10610464)

  • 1. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease.
    Cohen DJ; Carrozza JP; Baim DS
    N Engl J Med; 1999 Dec; 341(24):1853-4; author reply 1854-5. PubMed ID: 10610464
    [No Abstract]   [Full Text] [Related]  

  • 2. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease.
    Ricciardi MJ; Davidson CJ
    N Engl J Med; 1999 Dec; 341(24):1854; author reply 1854-5. PubMed ID: 10610465
    [No Abstract]   [Full Text] [Related]  

  • 3. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease.
    Bloom JM
    N Engl J Med; 1999 Dec; 341(24):1854-5. PubMed ID: 10610466
    [No Abstract]   [Full Text] [Related]  

  • 4. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.
    Pitt B; Waters D; Brown WV; van Boven AJ; Schwartz L; Title LM; Eisenberg D; Shurzinske L; McCormick LS
    N Engl J Med; 1999 Jul; 341(2):70-6. PubMed ID: 10395630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and design of the Myocardial Ischemia Reduction With Aggressive Cholesterol lowering (MIRACL) Study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction.
    Ghali JK
    Am J Cardiol; 1998 Sep; 82(5):703. PubMed ID: 9732912
    [No Abstract]   [Full Text] [Related]  

  • 6. Statin therapy and the elderly: SAGE advice?
    Gotto AM
    Circulation; 2007 Feb; 115(6):681-3. PubMed ID: 17296867
    [No Abstract]   [Full Text] [Related]  

  • 7. Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE)-rationale and design of atorvastatin versus usual care in hypercholesterolemic patients with coronary artery disease.
    Isaacsohn JL; Davidson MH; Hunninghake D; Singer R; McLain R; Black DM
    Am J Cardiol; 2000 Jul; 86(2):250-2. PubMed ID: 10913499
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the Elderly (SAGE).
    Deedwania P; Stone PH; Bairey Merz CN; Cosin-Aguilar J; Koylan N; Luo D; Ouyang P; Piotrowicz R; Schenck-Gustafsson K; Sellier P; Stein JH; Thompson PL; Tzivoni D
    Circulation; 2007 Feb; 115(6):700-7. PubMed ID: 17283260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Meeting report. "MIRACL" study of "Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering"].
    Scheen AJ
    Rev Med Liege; 2000 Dec; 55(12):1064-6. PubMed ID: 11205194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is aggressive lipid-lowering therapy preferable to angioplasty in stable coronary artery disease?
    Ellis PM
    Med J Aust; 2001 Nov; 175(9):492-3. PubMed ID: 11758081
    [No Abstract]   [Full Text] [Related]  

  • 11. [AVERT study (Atorvastatin Versus Revascularization Treatment). Clinical advantage of aggressive lipid lowering].
    Z Kardiol; 1999 Mar; 88(3 Suppl):1-4. PubMed ID: 10330699
    [No Abstract]   [Full Text] [Related]  

  • 12. Atorvastatin for acute coronary syndromes.
    Schwartz GG; Olsson AG; Ezekowitz MD; Ganz P; Oliver MF; Waters D; Zeiher A; Chaitman BR
    JAMA; 2001 Aug; 286(5):533-5. PubMed ID: 11476650
    [No Abstract]   [Full Text] [Related]  

  • 13. A pharmacoeconomic evaluation of the Myocardial Ischaemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study in the United Kingdom.
    Buller N; Gillen D; Casciano R; Doyle J; Wilson K
    Pharmacoeconomics; 2003; 21 Suppl 1():25-32. PubMed ID: 12648032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive lipid-lowering in stable patients with coronary artery disease.
    Supanich B
    J Fam Pract; 1999 Oct; 48(10):749-50. PubMed ID: 12224668
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of atorvastatin on peripheral endothelial function and systemic inflammatory markers in patients with stable coronary artery disease.
    Alber HF; Frick M; Süssenbacher A; Dörler J; Dichtl W; Stocker EM; Pachinger O; Weidinger F
    Wien Med Wochenschr; 2007 Feb; 157(3-4):73-8. PubMed ID: 17340064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale, design, and baseline characteristics of a trial comparing aggressive lipid lowering with Atorvastatin Versus Revascularization Treatments (AVERT).
    McCormick LS; Black DM; Waters D; Brown WV; Pitt B
    Am J Cardiol; 1997 Nov; 80(9):1130-3. PubMed ID: 9359537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical therapy versus revascularization: the atorvastatin versus revascularization treatment AVERT trial.
    Waters DD
    Can J Cardiol; 2000 Jan; 16 Suppl A():11A-3A. PubMed ID: 10653925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Atorvastatin in secondary prevention].
    Ongen Z; Yilmaz Y; Karadağ B
    Turk Kardiyol Dern Ars; 2009 Mar; 37 Suppl 2():23-8. PubMed ID: 19404047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [LDL cholesterol in normal range. The lower the better? Implications of the GREACE study].
    März W
    MMW Fortschr Med; 2003 Dec; 145(50):46-9. PubMed ID: 14963971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous coronary intervention versus medical therapy for coronary heart disease.
    Maron DJ
    Curr Atheroscler Rep; 2000 Jul; 2(4):290-6. PubMed ID: 11122756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.